Type of Cancer
Leukemia
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 3, Randomized, Open-Label, Crossover Study of ASTX727 (Cedazuridine and Decitabine Fixed-Dose Combination) versus IV Decitabine in Subjects with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.